Compound Profiles
ACE-031
Myostatin Inhibitor | Experimental Muscle Growth
ACE-031 acts as a ligand trap for members of the TGF-beta superfamily. By mimicking the extracellular domain of the ActRIIB receptor, it intercepts myostatin (GDF-8), activin A, activin B, and GDF-11 before they can bind cell-surface receptors and activate Smad2/3 signaling.
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take ACE-031 with BPC-157?
Combining ACE-031 with BPC-157 is not recommended. Both ACE-031 and BPC-157 have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision.
Is ACE-031 and BPC-157 safe together?
This combination carries significant risk. Both ACE-031 and BPC-157 have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision. Consult a healthcare professional before combining.
What are the interactions between ACE-031 and BPC-157?
Both ACE-031 and BPC-157 have anticoagulant or blood-thinning effects. Combined use significantly increases bleeding risk. Avoid unless under direct medical supervision. This assessment has 49% confidence and is inferred from pharmacological mechanism analysis.
How should I time ACE-031 and BPC-157?
ACE-031 has a half-life of 12-15 days and BPC-157 has a half-life of <30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.